ClinicalTrials.Veeva

Menu

The Relationship of Multifidus and Gastrocnemius Muscle Thickness With Postural Stability in Patients With Stroke

U

Uskudar State Hospital

Status

Not yet enrolling

Conditions

Stroke
Postural; Defect
Hemiplegia

Treatments

Other: Measurement of multifidus and gastrocnemius muscle thickness with Ultrasound
Other: Berg Balance Scale

Study type

Observational

Funder types

Other

Identifiers

NCT05871723
SVOposture1

Details and patient eligibility

About

This study aims to investigate the relationship between multifidus and gastrocnemius muscle thickness with postural stability in patients with stroke.

Full description

Multifidus and gastrocnemius muscle thickness will be measured using ultrasound imaging. Postural stability will be assessed using the Berg Balance Scale, a clinical balance test that assesses an individual's ability to maintain balance during various functional tasks. The Berg Balance Scale includes 14 items, such as standing unsupported, reaching forward, turning, and standing on one leg. The Berg Balance Scale is a widely used clinical balance test that has good reliability and validity in stroke patients. Data will be analyzed using appropriate statistical methods, including correlation and regression analysis, to investigate the relationship between the multifidus and gastrocnemius muscle thickness and postural stability.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with stroke: Patients who have a confirmed diagnosis of stroke based on medical history, clinical examination, and diagnostic imaging.
  • Time since stroke onset: The trial may include patients who are at least 6 months post-stroke onset.
  • Ability to understand instructions: Patients who are able to understand and follow instructions provided for the study procedures.
  • Ability to provide informed consent: Patients who are able to provide informed consent or have a legal representative who can provide informed consent on their behalf.

Exclusion criteria

  • Cognitive impairment: Patients who have significant cognitive impairment that may affect their ability to follow instructions or participate in the study procedures.
  • Severe motor deficits: Patients with severe motor deficits that may limit their ability to perform the study procedures.
  • Other medical conditions: Patients with other medical conditions or comorbidities that may affect muscle thickness or postural stability, such as Parkinson's disease, multiple sclerosis, or severe osteoarthritis.
  • Inability to tolerate testing: Patients who are unable to tolerate the testing procedures, such as the Berg Balance Scale or ultrasound imaging.
  • Implanted devices: Patients with implanted devices, such as pacemakers, that may be affected by the ultrasound imaging.
  • Not giving consent.

Trial design

30 participants in 1 patient group

Stroke Patients
Description:
Patients diagnosed with stroke.
Treatment:
Other: Measurement of multifidus and gastrocnemius muscle thickness with Ultrasound
Other: Berg Balance Scale

Trial contacts and locations

0

Loading...

Central trial contact

Mustafa H Temel, M.D.; Fatih Bağcıer, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems